Optiver Holding
ALDX icon

Optiver Holding’s Aldeyra Therapeutics ALDX Stock Holding History

Optiver Holding’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.57K Sell
4,022
-544
-12% -$935 ﹤0.01% 1779
2026
Q1 		$7.72K Buy
4,566
+3,586
+366% +$15.7K ﹤0.01% 1287
2025
Q4 		$5.08K Hold
980
– – ﹤0.01% 1362
2025
Q3 		$5.12K Buy
+980
New +$5.11K ﹤0.01% 1720

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Optiver Holding's ALDX Position: Q2 2026 in Review

Optiver Holding reduced its Aldeyra Therapeutics (ALDX) stake by 12% in Q2 2026, selling an estimated $935 and leaving 4,022 shares worth $8.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1779.

Optiver Holding first reported a position in ALDX in Q3 2025 and has held it in 4 quarters since. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Optiver Holding held 4,022 shares of Aldeyra Therapeutics worth $8.57K as of Q2 2026.
  • Optiver Holding sold 544 Aldeyra Therapeutics shares in Q2 2026, an estimated $935.
  • Aldeyra Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1779 holding.
  • Optiver Holding first reported a position in Aldeyra Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.